Insights into retention and safety/tolerability of apomorphine sublingual film in patients with Parkinson’s disease and OFF episodes: post hoc analyses of a phase III, open-label study

Background: Managing OFF episodes in patients with Parkinson’s disease becomes increasingly challenging over time, making it critical to tailor treatment to each patient’s needs and characteristics for effective care. Objectives: Study CTH-301 assessed the long-term safety/tolerability and efficacy...

Descrición completa

Detalles Bibliográficos

Principais autores:	Jan Kassubek, Diego Santos Garcia, Wolfgang H. Jost, Lars Wojtecki, Fradique Moreira, Miguel M. Fonseca, Glynn Harrison-Jones, Isabel Pijuan, Carmen Denecke Muhr
Formato:	Artigo
Idioma:	Inglês
Publicado:	SAGE Publishing 2025-06-01
Series:	Therapeutic Advances in Neurological Disorders
Acceso en liña:	https://doi.org/10.1177/17562864251343583
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!